[go: up one dir, main page]

NO302176B1 - Process for the preparation of a monoclonal antibody and an antigen - Google Patents

Process for the preparation of a monoclonal antibody and an antigen

Info

Publication number
NO302176B1
NO302176B1 NO934897A NO934897A NO302176B1 NO 302176 B1 NO302176 B1 NO 302176B1 NO 934897 A NO934897 A NO 934897A NO 934897 A NO934897 A NO 934897A NO 302176 B1 NO302176 B1 NO 302176B1
Authority
NO
Norway
Prior art keywords
antigen
preparation
monoclonal antibody
monoclonal
antibody
Prior art date
Application number
NO934897A
Other languages
Norwegian (no)
Other versions
NO934897L (en
NO934897D0 (en
Inventor
Mary Kathleen Shriver
Elaine K Thomas
Wesley L Cosand
Larry H Gosting
Edna S Dickinson
Janela Mcclure
George J Todaro
Robert C Nowinski
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of NO934897L publication Critical patent/NO934897L/en
Publication of NO934897D0 publication Critical patent/NO934897D0/en
Publication of NO302176B1 publication Critical patent/NO302176B1/en

Links

Classifications

    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
    • F04B25/00—Multi-stage pumps
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K16/1143—
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO934897A 1986-08-20 1993-12-29 Process for the preparation of a monoclonal antibody and an antigen NO302176B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89827386A 1986-08-20 1986-08-20
US4502687A 1987-05-01 1987-05-01
US6799687A 1987-06-29 1987-06-29

Publications (3)

Publication Number Publication Date
NO934897L NO934897L (en) 1993-12-29
NO934897D0 NO934897D0 (en) 1993-12-29
NO302176B1 true NO302176B1 (en) 1998-02-02

Family

ID=27366600

Family Applications (2)

Application Number Title Priority Date Filing Date
NO873495A NO300462B1 (en) 1986-08-20 1987-08-19 Monoclonal antibodies and peptides that can be used to diagnose HIV infections
NO934897A NO302176B1 (en) 1986-08-20 1993-12-29 Process for the preparation of a monoclonal antibody and an antigen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO873495A NO300462B1 (en) 1986-08-20 1987-08-19 Monoclonal antibodies and peptides that can be used to diagnose HIV infections

Country Status (28)

Country Link
JP (1) JPS6485928A (en)
KR (1) KR920008744B1 (en)
AT (1) AT398080B (en)
AU (1) AU616156B2 (en)
BE (1) BE1000811A4 (en)
CH (1) CH675728A5 (en)
CS (1) CS275838B6 (en)
DE (1) DE3727703A1 (en)
DK (1) DK433087A (en)
ES (1) ES2010727A6 (en)
FI (1) FI873553A7 (en)
FR (1) FR2603107B1 (en)
GB (1) GB2196634B (en)
GR (1) GR871298B (en)
HU (1) HU214439B (en)
IE (1) IE60671B1 (en)
IL (1) IL83580A (en)
IT (1) IT1222518B (en)
LU (1) LU86972A1 (en)
NL (1) NL8701950A (en)
NO (2) NO300462B1 (en)
NZ (1) NZ221440A (en)
OA (1) OA08652A (en)
PL (1) PL155084B1 (en)
PT (1) PT85567B (en)
SE (1) SE506025C2 (en)
YU (1) YU152587A (en)
ZW (1) ZW15487A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP96A (en) * 1986-06-03 1990-08-12 The Usa Dept Of Commerce Small peptides which inhibit binding to T-4 receptors and act as immunogens.
AU625720B2 (en) * 1987-05-01 1992-07-16 Genetic Systems Corporation Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
US5981278A (en) * 1987-05-29 1999-11-09 Tanox, Inc. Chimeric monoclonal antibodies which neutralize HIV-1 infection and their applications in therapy and prevention for AIDS
JP2520464B2 (en) * 1987-05-29 1996-07-31 タノツクス・バイオシステムズ・インコーポレーテツド Monoclonal antibody that neutralizes HIV-1
US5834599A (en) * 1987-05-29 1998-11-10 Tanox Biosystems, Inc. Immunoconjugates which neutralize HIV-1 infection
US6657050B1 (en) 1987-05-29 2003-12-02 Tanox, Inc. Chimeric viral-neutralizing immunoglobulins
ATE138077T1 (en) * 1988-01-26 1996-06-15 Us Health SYNTHETIC ANTIGEN FOR PRODUCING AN ANTI-HIV RESPONSE
CA1341285C (en) * 1988-02-12 2001-08-14 Chang Yi Wang Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
IL90048A0 (en) * 1988-04-25 1989-12-15 Merck & Co Inc Recombinant gag precursor of hiv,its preparation and its use as aids vaccine
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
FR2632310B1 (en) * 1988-06-06 1992-04-10 Pasteur Institut PEPTIDES HAVING PROTECTIVE PROPERTIES OF A PATHOGENIC VIRUS OF THE HIV TYPE IN SENSITIVE CELLS
AU640619B2 (en) * 1988-10-03 1993-09-02 Repligen Corporation Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
EP0421626A1 (en) * 1989-09-19 1991-04-10 Merck & Co. Inc. Vaccine for aids and hepatitis B
SE9000333D0 (en) * 1990-01-31 1990-01-31 Britta Wahren MONOCLONAL ANTIBODY
SE468168B (en) * 1990-02-20 1992-11-16 Replico Medical Ab HIV-1, P24 PEPTIDES, DIAGNOSTIC ANTIGENS AND PROCEDURES FOR DIFFERENTIAL DIAGNOSTICS OF PRELIMINARY HIV-1 POSITIVE SERUM TESTS
JPH03271233A (en) * 1990-03-19 1991-12-03 Inst Pasteur Induction of protection against viral infection by synergy between viral envelope glycoproteins and peptides corresponding to neutralizing epitopes of the glycoproteins
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
CA2047042A1 (en) * 1990-07-19 1992-01-20 John Hannah Cyclic hiv principal neutralizing determinant peptides
JPH05310785A (en) * 1991-09-30 1993-11-22 Nitto Denko Corp Hiv-related cyclic peptide and adsorption material obtained by immobilizing the same
DK0635027T3 (en) * 1992-03-27 2000-10-02 Advanced Immunit T Inc Peptide T and related peptides for the treatment of inflammation, including disseminated sclerosis
NZ604248A (en) 2005-12-09 2014-07-25 Vectus Biosystems Ltd Vip fragments and methods of use
JP5165751B2 (en) 2008-09-02 2013-03-21 日本特殊陶業株式会社 Spark plug
KR102727239B1 (en) * 2022-09-07 2024-11-07 한국세라믹기술원 Magnesium oxide powder and method for manufacturing the same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9328391B1 (en) * 1984-08-22 2016-05-03 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Cloning and expression of HIV-1 DNA
GB8501473D0 (en) * 1985-01-21 1985-02-20 Pasteur Institut Cloned dna sequences
EP0201540B2 (en) * 1984-10-18 2001-10-31 Institut Pasteur Envelope antigens of lymphadenopathy associated virus and their applications
CA1341482C (en) * 1984-10-31 2005-05-10 Paul A. Luciw Process for preparing fragments of aids-associated retroviruses
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
ES8706824A1 (en) * 1985-04-08 1987-07-01 Genetic Systems Corp EXPRESSION AND DIAGNOSTIC USE OF gag ENCODED PEPTIDES WHICH ARE IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES TO LAV.
FI861626A7 (en) * 1985-04-19 1986-10-20 Hoffmann La Roche FOERVAERVAT IMMUNBRIST SYNDROME (AIDS) -RELATERAT VIRALT RECOMBINANT HOELJEPROTEIN SAMT ETT TESTFOERFARANDE FOER AIDS.
DE3650175T3 (en) * 1985-04-29 2007-09-06 Bio-Rad Laboratories, Inc., Hercules SYNTHETIC ANTIGENIC TO IDENTIFY AIDS.
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
ATE108022T1 (en) * 1985-10-24 1994-07-15 Southwest Found Biomed Res SYNTHETIC PEPTIDES AND THEIR USE IN DIAGNOSIS AND VACCINATION FOR AIDS AND ARC.
EP0245459B1 (en) * 1985-11-07 1993-09-29 The President And Fellows Of Harvard College T-cell lymphotrophic virus protein and assay
US4772547A (en) * 1986-02-03 1988-09-20 Hoffmann-La Roche Inc. HTLV-III envelope peptides
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
IE63109B1 (en) * 1986-06-23 1995-03-22 Genetic Systems Corp Human monoclonal antibody to lymphadenopathy-associated virus
EP0255190A3 (en) * 1986-08-01 1990-08-29 Repligen Corporation Recombinant polypeptides and their uses, inclusing assay for aids virus
JPH0762031B2 (en) * 1986-12-30 1995-07-05 アメリカ合衆国 Synthetic peptides that induce cell-mediated immunity to AIDS virus and AIDS virus proteins

Also Published As

Publication number Publication date
HU214439B (en) 1998-03-30
IT8721678A0 (en) 1987-08-19
ZW15487A1 (en) 1988-09-14
PL155084B1 (en) 1991-10-31
KR920008744B1 (en) 1992-10-09
ES2010727A6 (en) 1989-12-01
FR2603107B1 (en) 1992-04-24
DE3727703A1 (en) 1988-05-05
DK433087A (en) 1988-02-21
ATA208987A (en) 1994-01-15
AU7720187A (en) 1988-05-19
GR871298B (en) 1988-01-12
GB8719587D0 (en) 1987-09-23
FI873553A0 (en) 1987-08-17
OA08652A (en) 1988-11-30
CS275838B6 (en) 1992-03-18
GB2196634A (en) 1988-05-05
PL267401A1 (en) 1988-07-21
NL8701950A (en) 1988-03-16
GB2196634B (en) 1991-05-15
SE506025C2 (en) 1997-11-03
PT85567A (en) 1987-09-01
PT85567B (en) 1991-02-08
NO300462B1 (en) 1997-06-02
IL83580A0 (en) 1988-01-31
SE8703225L (en) 1988-02-21
KR890002547A (en) 1989-04-10
NO873495D0 (en) 1987-08-19
IE872219L (en) 1988-02-20
NO873495L (en) 1988-02-22
NO934897L (en) 1993-12-29
IT1222518B (en) 1990-09-05
AU616156B2 (en) 1991-10-24
IL83580A (en) 1992-11-15
CH675728A5 (en) 1990-10-31
JPS6485928A (en) 1989-03-30
IE60671B1 (en) 1994-08-10
YU152587A (en) 1992-09-07
NO934897D0 (en) 1993-12-29
FI873553L (en) 1988-02-21
CS8706136A2 (en) 1990-08-14
FR2603107A1 (en) 1988-02-26
FI873553A7 (en) 1988-02-21
LU86972A1 (en) 1988-03-02
AT398080B (en) 1994-09-26
DK433087D0 (en) 1987-08-19
SE8703225D0 (en) 1987-08-19
BE1000811A4 (en) 1989-04-11
HUT44619A (en) 1988-03-28
NZ221440A (en) 1991-11-26

Similar Documents

Publication Publication Date Title
NO302176B1 (en) Process for the preparation of a monoclonal antibody and an antigen
FI954347L (en) Monoclonal antibody compositions and hybridomas producing monoclonal antibodies
FI925631L (en) MONOCLONAL ANTIBODY
DK666389A (en) MONOCLONAL ANTIBODY
DK98187A (en) MONOCLONAL ANTIBODIES AND ANTIGEN FOR HUMAN NON-SMALL CELL LUNGCARCINOMA AND CERTAIN OTHER TYPES OF HUMAN CARCINOMA
DK63187D0 (en) ANTIBODY MONOCLONAL ANTIBODY PREPARATIONS
BE888906A (en) PROCESS FOR THE PREPARATION OF AN INTESTINAL GLUCAGON ANTIGEN AND ANTIBODY
DE3689948D1 (en) MONOCLONAL ANTIBODIES AND TEST PROCEDURE.
DK610587A (en) METHOD AND METHOD OF ANY ANTIBODY FOR HEPATITIS B CORE ANTIGEN
FI895287A7 (en) Anti-fucosylceramide monoclonal antibody
EP0285511A3 (en) Monoclonal antibodies and their uses
NO170691C (en) ONCOPHETAL SPECIFIC MONOCLONAL ANTIBODIES AND USE THEREOF
PT66996B (en) A method for the assay of antigen and antibody
EP0267601A3 (en) Anti-pci monoclonal antibody
DK717888D0 (en) MONOCLONAL ANTIBODIES
GB8804802D0 (en) Preparation of monoclonal antibodies
DK474189A (en) MONOCLONAL ANTIBODY
DE3066975D1 (en) Propranolol antigen conjugates and antibodies and method of using them
HU895916D0 (en) Process for the preparation of monoclonal antibody recognaizing reg protein
DK413389A (en) MONOCLONAL ANTIBODIES
FI914924A7 (en) Monoclonal antibody for distinguishing squamous cell carcinoma antigens and method of using the same
NO941347D0 (en) Process for the preparation of a human monoclonal antibody
PT66997B (en) A method for the assay of antigen and antibody
EP0265847A3 (en) Monoclonal antibody
ZW9888A1 (en) Monoclonal antibodies and methods for diagnosis of pytophthora infection